MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hemifacial spasm(HFS)"

  • 2019 International Congress

    Hemifacial spasm management: 26-year experience

    Y. Herrero-Infante, A. Rodriguez-Sanz, J. Mañez-Miró, F. Vivancos-Matellano (Madrid, Spain)

    Objective: To analyze the causes of hemifacial spasm as well as the efficacy and safety of long term treatment with botulinum toxin (BT). Background: Hemifacial…
  • 2019 International Congress

    A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin

    SK. Yang, JJ. Lin (Changhua County, Taiwan)

    Objective: To report a case with hemimasticatory spasm responsive to serial botulinum toxin injections. Background: Hemimasticatory spasm is a rare neurologic disorder characterized by involuntary…
  • 2019 International Congress

    The effects of onabotulinum toxin on neurophysiological tests in patients with hemifacial spasm

    O. Kocak, A. Tokcaer (Ankara, Turkey)

    Objective: We aimed to investigate effects of onabotulinum toxin (OnaBoNT) on clinical and neurophysiological findings of patients with hemifacial spasm (HFS). Background: There is a…
  • 2019 International Congress

    Hemifacial Spasm and Related Comorbidities

    A. Akyol Gurses, N. Kiylioglu, A. Akyol (Aydin, Turkey)

    Objective: In this study, we evaluated the clinical findings, comorbidities and teratment responses in our HFS patients. Background: Hemifacial spasm (HFS) is a peripherally induced…
  • 2018 International Congress

    Effect of Cold Compression Before Botulinum Neurotoxin Injection in Hemifacial Spasm

    P. Dhanachanvisith, T. Tantirittisak (Bangkok, Thailand)

    Objective: To compare effect of cold compression and no cold compression before Botulinum neurotoxin (BoNT) injection on severity, frequency of hemifacial spasm (HFS) and complication…
  • 2018 International Congress

    Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study

    A. Suengtaworn, Y. Pitakpatapee, P. Soontrapa, C. Hurst, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics, along with the treatment outcomes of botulinum neurotoxin (BoNT) between HFS patients with and without the BBK-2 sign as…
  • 2018 International Congress

    The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients

    Y. Pitakpatapee, A. Suengtaworn, P. Soontrapa, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics and treatment outcomes after injection of botulinum neurotoxin (BoNT) type A between non-troublesome and troublesome hemifacial spasm (HFS) in…
  • 2018 International Congress

    Non-motor symptoms and alteration of brain networks in patients with blepharospasm and hemifacial spasm

    YJ. Guo, CM. Chen, MH. Chang (Taichung, Taiwan)

    Objective: To investigate the differences of non-motor symptoms and the alteration of intrinsic brain networks in patients with blepharospasm and hemifacial spam. Background: Blepharospasm (BSP)…
  • 2018 International Congress

    Assessing hemifacial spasm: The HFSG scale

    S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…
  • 2017 International Congress

    Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

    O. Dogu, H. Kalegasi (Mersin, Turkey)

    Objective: To assess the frequency of Babinski-2 sign among patients with hemifacial spasm (HFS). Background: The Babinski-2 sign (“the other” Babinski sign, “brow-lift sign”), is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley